TY - JOUR A1 - Aktas, Bertal H. A1 - Upcin, Berin A1 - Henke, Erik A1 - Padmasekar, Manju A1 - Qin, Xuebin A1 - Ergün, Süleyman T1 - The Best for the Most Important: Maintaining a Pristine Proteome in Stem and Progenitor Cells JF - Stem Cells International N2 - Pluripotent stem cells give rise to reproductively enabled offsprings by generating progressively lineage-restricted multipotent stem cells that would differentiate into lineage-committed stem and progenitor cells. These lineage-committed stem and progenitor cells give rise to all adult tissues and organs. Adult stem and progenitor cells are generated as part of the developmental program and play critical roles in tissue and organ maintenance and/or regeneration. The ability of pluripotent stem cells to self-renew, maintain pluripotency, and differentiate into a multicellular organism is highly dependent on sensing and integrating extracellular and extraorganismal cues. Proteins perform and integrate almost all cellular functions including signal transduction, regulation of gene expression, metabolism, and cell division and death. Therefore, maintenance of an appropriate mix of correctly folded proteins, a pristine proteome, is essential for proper stem cell function. The stem cells' proteome must be pristine because unfolded, misfolded, or otherwise damaged proteins would interfere with unlimited self-renewal, maintenance of pluripotency, differentiation into downstream lineages, and consequently with the development of properly functioning tissue and organs. Understanding how various stem cells generate and maintain a pristine proteome is therefore essential for exploiting their potential in regenerative medicine and possibly for the discovery of novel approaches for maintaining, propagating, and differentiating pluripotent, multipotent, and adult stem cells as well as induced pluripotent stem cells. In this review, we will summarize cellular networks used by various stem cells for generation and maintenance of a pristine proteome. We will also explore the coordination of these networks with one another and their integration with the gene regulatory and signaling networks. KW - Endoplasmic-Reticulum Stress KW - Heme-regulated inhibitor KW - Human Muse Cells KW - Transcription factor NRF1 KW - ER-Stress KW - Hematopoietic Stem KW - Quality-control KW - Messenger-RNAs KW - Neural Differentiation KW - Translation Initiation Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-227769 ER - TY - JOUR A1 - Rossow, Leonie A1 - Veitl, Simona A1 - Vorlová, Sandra A1 - Wax, Jacqueline K. A1 - Kuhn, Anja E. A1 - Maltzahn, Verena A1 - Upcin, Berin A1 - Karl, Franziska A1 - Hoffmann, Helene A1 - Gätzner, Sabine A1 - Kallius, Matthias A1 - Nandigama, Rajender A1 - Scheld, Daniela A1 - Irmak, Ster A1 - Herterich, Sabine A1 - Zernecke, Alma A1 - Ergün, Süleyman A1 - Henke, Erik T1 - LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy JF - Oncogene N2 - The potential of altering the tumor ECM to improve drug response remains fairly unexplored. To identify targets for modification of the ECM aiming to improve drug response and overcome resistance, we analyzed expression data sets from pre-treatment patient cohorts. Cross-evaluation identified a subset of chemoresistant tumors characterized by increased expression of collagens and collagen-stabilizing enzymes. We demonstrate that strong collagen expression and stabilization sets off a vicious circle of self-propagating hypoxia, malignant signaling, and aberrant angiogenesis that can be broken by an appropriate auxiliary intervention: Interfering with collagen stabilization by inhibition of lysyl oxidases significantly enhanced response to chemotherapy in various tumor models, even in metastatic disease. Inhibition of collagen stabilization by itself can reduce or enhance tumor growth depending on the tumor type. The mechanistical basis for this behavior is the dependence of the individual tumor on nutritional supply on one hand and on high tissue stiffness for FAK signaling on the other. KW - Cancer models KW - Cancer therapeutic resistance KW - Targeted therapies KW - Tumour angiogenesis Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-227008 VL - 37 ER - TY - JOUR A1 - Upcin, Berin A1 - Henke, Erik A1 - Kleefeldt, Florian A1 - Hoffmann, Helene A1 - Rosenwald, Andreas A1 - Irmak-Sav, Ster A1 - Aktas, Huseyin Bertal A1 - Rückschloß, Uwe A1 - Ergün, Süleyman T1 - Contribution of adventitia-derived stem and progenitor cells to new vessel formation in tumors JF - Cells N2 - Blocking tumor vascularization has not yet come to fruition to the extent it was hoped for, as angiogenesis inhibitors have shown only partial success in the clinic. We hypothesized that under- appreciated vascular wall-resident stem and progenitor cells (VW-SPCs) might be involved in tumor vascularization and influence effectiveness of anti-angiogenic therapy. Indeed, in patient samples, we observed that vascular adventitia-resident CD34\(^+\) VW-SPCs are recruited to tumors in situ from co-opted vessels. To elucidate this in detail, we established an ex vivo model using concomitant embedding of multi-cellular tumor spheroids (MCTS) and mouse aortic rings (ARs) into collagen gels, similar to the so-called aortic ring assay (ARA). Moreover, ARA was modified by removing the ARs’ adventitia that harbors VW-SPCs. Thus, this model enabled distinguishing the contribution of VW-SPCs from that of mature endothelial cells (ECs) to new vessel formation. Our results show that the formation of capillary-like sprouts is considerably delayed, and their number and network formation were significantly reduced by removing the adventitia. Substituting iPSC-derived neural spheroids for MCTS resulted in distinct sprouting patterns that were also strongly influenced by the presence or absence of VW-SPCs, also underlying the involvement of these cells in non-pathological vascularization. Our data suggest that more comprehensive approaches are needed in order to block all of the mechanisms contributing to tumor vascularization. KW - vascularization model KW - tumor spheroids KW - vascular wall stem and progenitor cells KW - aortic adventitia KW - vasculogenesis KW - tumor-vessel wall-interface model Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-242577 VL - 10 IS - 7 ER - TY - JOUR A1 - Wörsdörfer, Philipp A1 - Dalda, Nahide A1 - Kern, Anna A1 - Krüger, Sarah A1 - Wagner, Nicole A1 - Kwok, Chee Keong A1 - Henke, Erik A1 - Ergün, Süleyman T1 - Generation of complex human organoid models including vascular networks by incorporation of mesodermal progenitor cells JF - Scientific Reports N2 - Organoids derived from human pluripotent stem cells are interesting models to study mechanisms of morphogenesis and promising platforms for disease modeling and drug screening. However, they mostly remain incomplete as they lack stroma, tissue resident immune cells and in particular vasculature, which create important niches during development and disease. We propose, that the directed incorporation of mesodermal progenitor cells (MPCs) into organoids will overcome the aforementioned limitations. In order to demonstrate the feasibility of the method, we generated complex human tumor as well as neural organoids. We show that the formed blood vessels display a hierarchic organization and mural cells are assembled into the vessel wall. Moreover, we demonstrate a typical blood vessel ultrastructure including endothelial cell-cell junctions, a basement membrane as well as luminal caveolae and microvesicles. We observe a high plasticity in the endothelial network, which expands, while the organoids grow and is responsive to anti-angiogenic compounds and pro-angiogenic conditions such as hypoxia. We show that vessels within tumor organoids connect to host vessels following transplantation. Remarkably, MPCs also deliver Iba1\(^+\) cells that infiltrate the neural tissue in a microglia-like manner. KW - Developmental biology KW - Stem cells Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-202681 VL - 9 ER - TY - JOUR A1 - Henke, Erik A1 - Nandigama, Rajender A1 - Ergün, Süleyman T1 - Extracellular matrix in the tumor microenvironment and its impact on cancer therapy JF - Frontiers in Molecular Biosciences N2 - Solid tumors are complex organ-like structures that consist not only of tumor cells but also of vasculature, extracellular matrix (ECM), stromal, and immune cells. Often, this tumor microenvironment (TME) comprises the larger part of the overall tumor mass. Like the other components of the TME, the ECM in solid tumors differs significantly from that in normal organs. Intratumoral signaling, transport mechanisms, metabolisms, oxygenation, and immunogenicity are strongly affected if not controlled by the ECM. Exerting this regulatory control, the ECM does not only influence malignancy and growth of the tumor but also its response toward therapy. Understanding the particularities of the ECM in solid tumor is necessary to develop approaches to interfere with its negative effect. In this review, we will also highlight the current understanding of the physical, cellular, and molecular mechanisms by which the pathological tumor ECM affects the efficiency of radio-, chemo-, and immunotherapy. Finally, we will discuss the various strategies to target and modify the tumor ECM and how they could be utilized to improve response to therapy. KW - extracellular matrix KW - cancer therapy KW - drug transport KW - immunotherapy KW - chemotherapy (CH) KW - radiotherapy KW - tumor microenvironment KW - ECM Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-199341 SN - 2296-889X VL - 6 IS - 160 ER - TY - JOUR A1 - Schütze, Friedrich A1 - Röhring, Florian A1 - Vorlová, Sandra A1 - Gätzner, Sabine A1 - Kuhn, Anja A1 - Ergün, Süleyman A1 - Henke, Erik T1 - Inhibition of lysyl oxidases improves drug diffusion and increases efficacy of cytotoxic treatment in 3D tumor models JF - Scientific Reports N2 - Tumors are characterized by a rigid, highly cross-linked extracellular matrix (ECM), which impedes homogeneous drug distribution and potentially protects malignant cells from exposure to therapeutics. Lysyl oxidases are major contributors to tissue stiffness and the elevated expression of these enzymes observed in most cancers might influence drug distribution and efficacy. We examined the effect of lysyl oxidases on drug distribution and efficacy in 3D in vitro assay systems. In our experiments elevated lysyl oxidase activity was responsible for reduced drug diffusion under hypoxic conditions and consequently impaired cytotoxicity of various chemotherapeutics. This effect was only observed in 3D settings but not in 2D-cell culture, confirming that lysyl oxidases affect drug efficacy by modification of the ECM and do not confer a direct desensitizing effect. Both drug diffusion and efficacy were strongly enhanced by inhibition of lysyl oxidases. The results from the in vitro experiments correlated with tumor drug distribution in vivo, and predicted response to therapeutics in murine tumor models. Our results demonstrate that lysyl oxidase activity modulates the physical barrier function of ECM for small molecule drugs influencing their therapeutic efficacy. Targeting this process has the potential to significantly enhance therapeutic efficacy in the treatment of malignant diseases. KW - human osteosarcoma xenografts KW - factor binding profiles KW - open-access database KW - vascular normalization KW - solid tumors KW - transcapillary pressure gradient KW - hypoxia inducible factor 1 KW - breast cancer cells KW - beta-aminopropionitrile KW - pancreatic cancer Y1 - 2015 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-145109 VL - 5 IS - 17576 ER - TY - JOUR A1 - Sagiv, Jitka Y. A1 - Michaeli, Janna A1 - Assi, Simaan A1 - Mishalian, Inbal A1 - Kisos, Hen A1 - Levy, Liran A1 - Damti, Pazzit A1 - Lumbroso, Delphine A1 - Polyansky, Lola A1 - Sionov, Ronit V. A1 - Ariel, Amiram A1 - Hovav, Avi-Hai A1 - Henke, Erik A1 - Fridlender, Zvi G. A1 - Granot, Zvi T1 - Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer JF - Cell Reports N2 - Controversy surrounds neutrophil function in cancer because neutrophils were shown to provide both pro-and antitumor functions. We identified a heterogeneous subset of low-density neutrophils (LDNs) that appear transiently in self-resolving inflammation but accumulate continuously with cancer progression. LDNs display impaired neutrophil function and immunosuppressive properties, characteristics that are in stark contrast to those of mature, high-density neutrophils (HDNs). LDNs consist of both immature myeloid-derived suppressor cells (MDSCs) and mature cells that are derived from HDNs in a TGF-beta-dependent mechanism. Our findings identify three distinct populations of circulating neutrophils and challenge the concept that mature neutrophils have limited plasticity. Furthermore, our findings provide a mechanistic explanation to mitigate the controversy surrounding neutrophil function in cancer. KW - tumorigenic properties KW - innate immunity KW - adenocarcinoma KW - inhibition KW - model KW - suppressor cells KW - tumor KW - TGF-beta KW - mice KW - lung Y1 - 2015 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-144102 VL - 10 IS - 4 ER -